Patents expiring in 2029

US 7566719

Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566732

Rhodanine compositions for use as antiviral agents

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566718

Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity

Pharmacopeia Drug Discovery, Inc. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566785

Amidine substituted aryl aniline compounds

Theravance, Inc. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566540

Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566462

Stable tablet formulation

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566451

Human immunodeficiency virus-neutralizing human antibodies with improved breadth and potency

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566465

Artemisinins in the clinical and veterinary management of kinetoplastid infections

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566552

Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors

CropDesign N.V. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566447

Biocides

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566714

Methods and compositions for the treatment of metabolic disorders

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2712282

COMPOSITION PHARMACEUTIQUE DE DULOXETINE A LIBERATION RETARDEE

ALPHAPHARM PTY LTD [AU] · Granted Thu Jul 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jul 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569604

Heterocyclic derivatives for modulation of calcium channels

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569591

Gyrase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569588

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569586

Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

Theravance, Inc. · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569580

Heterotricyclic compounds for use as HCV inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569570

Thienopyrimidines, process for preparing the same and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569386

Chondroitin synthase gene and methods of making and using same

The Board of Regents of the University of Oklahoma · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569673

Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569683

UspA2 nucleic acid of Moraxella catarrhalis

The Board of Regents of the University of Texas System · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569729

Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569542

Anti-microbial targeting chimeric pharmaceutical

The Regents of the University of California · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569697

Benzimidazole compound crystal

Takeda Pharmaceutical Company Limited · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569696

Process for producing crystal

Takeda Pharmaceutical Company Limited · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569340

Nanoarrays of single virus particles, methods and instrumentation for the fabrication and use thereof

Northwestern University · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569214

Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid

Nektar Therapeutics AL, Corporation · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572448

Combined cancer treatment methods using selected antibodies to aminophospholipids

The Board of Regents of the University of Texas System · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572771

Multi-domain amphipathic helical peptides and methods of their use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572789

Salts of potassium ATP channel openers and uses thereof

ESSENTIALIS, INC. · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572442

Selected antibody compositions for binding to aminophospholipids

The Board of Regents of the University of Texas System · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572887

Gene expressed in prostate cancer, methods and use thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572918

Process for preparing substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds

Theravance, Inc. · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572449

Vaccine against Yersinia comprising one or two antibodies, one specific for Yersinia pestis F1-antigen and the other one for Yersinia pestis V-antigen

The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572764

Uses of chemically-modified cholinesterases for detoxification of organophosporus compounds

State of Israel, Prime Minister's Office, Israel Insitute For Biological Research · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572828

Identification of anti-HIV compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572891

Kidney-specific tumor vaccine directed against kidney tumor antigen G-250

The Regents of the University of California · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572893

IL-1 antagonist formulations

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572914

Kinase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572920

Benzimidazole derivative and use as a II receptor antagonist

Takeda Pharmaceutical Company Limited · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7574340

Small molecules and a pharmacophore model for inhibition of botulinum toxin and methods of making and using thereof

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572788

Compositions and methods relating to novel compounds and targets thereof

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572834

Rasagiline formulations and processes for their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572641

Pharmaceutical compositions comprising meloxicam and methods of their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572574

Method of measuring neprilysin activity

Takeda Pharmaceutical Company Limited · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572245

Application of a therapeutic substance to a tissue location using an expandable medical device

ATRIUM MEDICAL CORPORATION · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572124

Apparatus for simultaneous illumination of teeth

DISCUS DENTAL, LLC · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2086964

BENZOYLAMINOHETEROCYCLYLVERBINDUNGEN, DIE SICH FÜR DIE BEHANDLUNG EINER DURCH GLK VERMITTELTEN KRANKHEIT EIGNEN

ASTRAZENECA AB [SE] · Granted Wed Aug 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Aug 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)